Insider Selling: Ryan Specialty Holdings, Inc. (NYSE:RYAN) Director Sells 35,000 Shares of Stock

Ryan Specialty Holdings, Inc. (NYSE:RYAN - Get Free Report) Director Nicholas Dominic Cortezi sold 35,000 shares of the firm's stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $66.71, for a total value of $2,334,850.00. Following the completion of the sale, the director now directly owns 60,200 shares in the company, valued at $4,015,942. This trade represents a 36.76 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Nicholas Dominic Cortezi also recently made the following trade(s):

• On Friday, December 13th, Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock. The stock was sold at an average price of $67.39, for a total transaction of $2,358,650.00.

Ryan Specialty Trading Down 1.5 %

Shares of NYSE RYAN traded down $1.01 during midday trading on Tuesday, reaching $65.44. The stock had a trading volume of 838,724 shares, compared to its average volume of 867,305. The company's 50 day moving average price is $70.80 and its 200 day moving average price is $64.64. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty Holdings, Inc. has a twelve month low of $41.57 and a twelve month high of $75.97. The firm has a market cap of $17.13 billion, a price-to-earnings ratio of 86.30, a price-to-earnings-growth ratio of 1.52 and a beta of 0.67.

Ryan Specialty (NYSE:RYAN - Get Free Report) last released its earnings results on Wednesday, October 30th. The company reported $0.41 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.41. Ryan Specialty had a net margin of 10.31% and a return on equity of 47.90%. The business had revenue of $604.69 million for the quarter, compared to analyst estimates of $602.04 million. During the same quarter in the previous year, the business earned $0.32 earnings per share. Ryan Specialty's revenue for the quarter was up 20.5% on a year-over-year basis. As a group, sell-side analysts expect that Ryan Specialty Holdings, Inc. will post 1.82 EPS for the current year.

Ryan Specialty Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Investors of record on Tuesday, November 12th were given a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.67%. Ryan Specialty's payout ratio is 57.14%.

Institutional Investors Weigh In On Ryan Specialty

Several large investors have recently added to or reduced their stakes in RYAN. Hollencrest Capital Management bought a new stake in Ryan Specialty in the third quarter valued at $25,000. Assetmark Inc. bought a new stake in Ryan Specialty in the 3rd quarter valued at about $34,000. Crewe Advisors LLC acquired a new position in Ryan Specialty during the 2nd quarter worth approximately $39,000. Quarry LP raised its stake in Ryan Specialty by 109.3% during the 3rd quarter. Quarry LP now owns 808 shares of the company's stock worth $54,000 after buying an additional 422 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in Ryan Specialty by 106.4% in the third quarter. GAMMA Investing LLC now owns 1,249 shares of the company's stock worth $83,000 after acquiring an additional 644 shares in the last quarter. Institutional investors and hedge funds own 84.82% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on RYAN. The Goldman Sachs Group upped their price objective on shares of Ryan Specialty from $64.00 to $72.00 and gave the stock a "neutral" rating in a research report on Wednesday, October 9th. Morgan Stanley started coverage on Ryan Specialty in a report on Thursday, December 5th. They set an "overweight" rating and a $90.00 price objective on the stock. BMO Capital Markets raised Ryan Specialty from a "market perform" rating to an "outperform" rating and upped their target price for the stock from $65.00 to $75.00 in a report on Tuesday, September 24th. Barclays lifted their price target on Ryan Specialty from $76.00 to $88.00 and gave the company an "overweight" rating in a research note on Thursday, November 21st. Finally, Wells Fargo & Company boosted their price target on Ryan Specialty from $63.00 to $70.00 and gave the stock an "equal weight" rating in a report on Thursday, October 10th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, Ryan Specialty has a consensus rating of "Hold" and a consensus target price of $73.50.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.